1 / 21

Sequential versus concurrent fludarabine and rituximab in previously untreated chronic lymphocytic leukaemia

Outline of presentation. Update of results from the randomised CALGB 9712 trial of sequential versus concurrent fludarabine and rituximab Retrospective comparison of response and survival data from CALGB 9712 (fludarabine and rituximab) and CALGB 9011 (fludarabine alone) studies. CALGB = Cancer and

dayton
Télécharger la présentation

Sequential versus concurrent fludarabine and rituximab in previously untreated chronic lymphocytic leukaemia

An Image/Link below is provided (as is) to download presentation Download Policy: Content on the Website is provided to you AS IS for your information and personal use and may not be sold / licensed / shared on other websites without getting consent from its author. Content is provided to you AS IS for your information and personal use only. Download presentation by click this link. While downloading, if for some reason you are not able to download a presentation, the publisher may have deleted the file from their server. During download, if you can't get a presentation, the file might be deleted by the publisher.

E N D

Presentation Transcript

    1. Sequential versus concurrent fludarabine and rituximab in previously untreated chronic lymphocytic leukaemia Dr T Lin College of Medicine and Public Health The Ohio State University, USA

More Related